Anthropic's CEO Dario Amodei has pushed back against criticism that his public statements about AI risks have fueled backlash against the technology, acknowledging that AI companies have not yet delivered on their promises to benefit society.
He endorsed the creation of a FINRA-like central regulator and argued that the best counter to criticism is tangible progress like curing cancer.
The company's Q2 revenue grew 14-fold to more than $11.5 billion, and it is targeting up to $200 billion in annual revenue by 2028 as it prepares for an IPO.
What happened
Anthropic CEO Dario Amodei acknowledged on social media that AI firms have not yet delivered on promises to benefit the world, while endorsing the creation of a FINRA-like central regulator. The company's Q2 revenue grew 14-fold to more than $11.5 billion.
Why it matters
Amodei's remarks directly address growing backlash against AI over concerns about power concentration and job displacement — concerns his own messaging has been seen as amplifying. His endorsement of regulatory oversight signals the industry's shift toward accepting stronger governance as a way to build public trust.
What to watch
Anthropic is targeting up to $200 billion in annual revenue by 2028 as it prepares for an IPO, meaning regulatory clarity and public perception will be critical to investor appetite and the company's valuation.
Ask the AI about this article →
Amodei's rare social media intervention represents a strategic pivot in how Anthropic frames the AI criticism debate. Rather than dismiss concerns about power centralization and job displacement, the CEO acknowledged that his industry has overpromised on near-term societal benefits. By endorsing a FINRA-like regulator — a reference to the financial industry's self-regulatory model — Amodei appears to be signaling that industry-led governance, rather than rejection of oversight, is the path forward. His assertion that "actually curing cancer" and other tangible breakthroughs are the real answer to criticism frames technological delivery as the ultimate validator of AI's social contract.
This positioning matters directly for Anthropic's IPO ambitions. The company's 14-fold Q2 revenue growth to more than $11.5 billion and its $200 billion annual revenue target by 2028 depend on investor confidence that the firm can navigate both technical and regulatory risk. In a climate where AI backlash is a real public and political force, Amodei's willingness to engage constructively with regulatory proposals and acknowledge unfulfilled promises may serve to differentiate Anthropic from competitors perceived as dismissive of concerns.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
AI system scaling has pushed interconnect requirements inside data centers from chips and boards up to racks…
Chinese large-model developer Z.ai says it can now support large-scale inference using roughly 100,000 domesti…
Analyst Ming-Chi Kuo says Nvidia has revived the Rubin CPX AI accelerator with a substantially redesigned arch…
Palantir Technologies stock has posted multi-year gains, including an 11x return over 3 years
Apple has escalated its legal battle against OpenAI, claiming in a new court filing that OpenAI is actively de…
Samsung Electronics has locked up as much as 70% of its memory production capacity under long-term supply agre…
